Dr France Emilie Roy, MD, FRCPC | |
3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 | |
(503) 494-5496 | |
Not Available |
Full Name | Dr France Emilie Roy |
---|---|
Gender | Female |
Speciality | Internal Medicine - Infectious Disease |
Location | 3181 Sw Sam Jackson Park Rd, Portland, Oregon |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1255804936 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZM0300X | Pathology - Medical Microbiology | MD190848 (Oregon) | Secondary |
207RI0200X | Internal Medicine - Infectious Disease | MD190848 (Oregon) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr France Emilie Roy, MD, FRCPC 535 Nw 11th Ave Apt 1106, Portland, OR 97209-4067 Ph: (418) 997-0597 | Dr France Emilie Roy, MD, FRCPC 3181 Sw Sam Jackson Park Rd, Portland, OR 97239-3011 Ph: (503) 494-5496 |
News Archive
MCN Learning, an internationally-recognized leader in healthcare education, announces the launch of the MCN Learning Pain Scale application for the Google Android mobile operating system.
New research examined SARS-CoV-2 transcripts in order to understand how it expresses its gene products in the infected host.
As the 69th World Health Assembly discusses progress on the Global Vaccine Action Plan, a new data visualization platform-from the International Vaccine Access Center at the Johns Hopkins Bloomberg School of Public Health-provides stark numbers on where shortfalls exist in vaccine introduction and coverage.
eDiets.com, Inc. today announced that it has completed its previously announced registered direct offering to select institutional investors for an aggregate of 5,275,000 shares. The shares were priced at $1.00 per share, resulting in total net proceeds of approximately $4.7 million, after deducting placement agent fees and other offering expenses.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.
› Verified 3 days ago
Salona Shrestha, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4805 Ne Glisan St, Portland, OR 97213 Phone: 503-215-2392 | |
Dr. Emmanuel Trungtoan Tavan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2800 N Vancouver Ave, Suite 230, Portland, OR 97227 Phone: 503-413-2901 | |
Ginevra Lois Liptan, M.D. Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 6400 Sw Canyon Ct, Ste 100, Portland, OR 97221 Phone: 503-477-9616 Fax: 503-477-9808 | |
Donald Richard Sullivan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Uhn67, Portland, OR 97239 Phone: 503-494-6949 | |
Dr. Victor Nguyen Pham, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9205 Sw Barnes Rd, Portland, OR 97225 Phone: 503-216-2906 | |
Richa Uppal, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 800 Sw 13th Ave, Portland, OR 97205 Phone: 503-221-0161 Fax: 503-274-1697 | |
Reem Hasan, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Ppv 350, Portland, OR 97239 Phone: 503-494-8562 |